Amneal Expects 2025 Revenues Of $3B-$3.1B And Adjusted EPS Of $0.65-$0.70 Versus Consensus Of $2.896B And $0.71, Respectively

Benzinga
02-28

2025 Financial Guidance

 Full Year 2025 GuidanceFull Year 2024 Actuals
Net revenue$3.0 billion - $3.1 billion$2.79 billion
Adjusted EBITDA (1)$650 million - $675 million$627 million
Adjusted diluted EPS (2)$0.65 - $0.70$0.58
Operating cash flow$255 million - $285 million$295 million
Operating cash flow, excluding discrete items (3)$280 million - $310 million$348 million
Capital expenditures (4)Approximately $100 million$52 million

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10